North America Warts Therapeutics Market is expected to reach US$ 869.8 million by 2028


PRESS RELEASE BY The Insight Partners 29 Sep 2021

Share this press on


Common Warts Segment has the Largest Share of Type in the North America Warts Therapeutics Market during 2021–2028

According to The Insight Partners market research study on “North America Warts Therapeutics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Treatment, and End User” is expected to reach US$ 869.8 million by 2028 from US$ 681.3 million in 2021. The market is estimated to grow at a CAGR of 3.5% from 2021 to 2028. The report provides trends prevailing in the North America Warts therapeutics market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising prevalence of human papillomavirus infections and recurrence of genital warts, and new product developments are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor diagnostics scenario in low-income countries.

The demand warts treatment is reduced due to Covid 19 as the focus of healthcare in overall world is on save lives in Covid 19 pandemic. The Covid 19, which is continuing to worsen around the world, is causing massive disruptions in global supply chains, consumer markets and the economy as a whole. As a result of the measures implemented by governments around the world. There is a risk of a temporary and significant decline in demand for dermatology treatment services Worldwide. For instance, in March 2020, regulations from the Centers for Medicare & Medicaid Services suggested that implementation of tele dermatology platforms in academic dermatology departments and changes to the iPledge system for isotretinoin prescribing that align well with telemedicine and the possibility of furthering the outreach of dermatologic care. However, as the vaccination drive progresses over the period of time the markets will come to normal situation which is expected to offer several opportunities for wart treatment market in North America region.

The market for warts therapeutics market is segmented into type, treatment, and end user. Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts and other. In 2020, the common warts segment is estimated to account for the largest market share in the warts therapeutics market. Common warts, or cutaneous warts, are abnormal epithelial growth in the skin and mucous membrane. Common warts are known to be caused by the Human Papilloma Virus (HPV). People with weakened immune system due to organ transplant, serious diseases, such as cancer or AIDS, and atopic diseases are at a greater risk of developing warts. Thus, an increase in number of people with cancer increases the prevalence of warts and consequently, drives the segment. Increase in number of HPV infections fuels the risk of warts and subsequently, boosts the market growth. However, genital warts are estimated to register the highest CAGR during the forecast period.

Bausch Health Companies Inc., Nielsen BioSciences, Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Novan, Inc., Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, and Verrica Pharmaceuticals Inc., GlaxoSmithKline plc., and AIM ImmunoTech Inc are among the leading companies in the North America warts therapeutics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2021, Teva Pharmaceuticals has launched First Generic Version of Absorica (isotretinoin) Capsules for Severe Recalcitrant Nodular Acne warts. Oral isotretinoin is a promising therapeutic choice for patients with refractory facial plane warts. 

The market for warts therapeutics market is segmented into type, treatment, and end user. Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts, and others. Based on treatment, the warts therapeutics market is segmented into physical destruction, immunomodulation, and chemical destruction. Based on end user, the warts therapeutics market is segmented into hospitals, homecare, specialty clinics, and others. Geographically, the warts therapeutics market is segmented into North America (US, Canada, Mexico).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

 

Download Free PDF Brochure